UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Diagnosis and Management of Pituitary Disorders

1, 2008

Volltextzugriff (PDF)

Improvements in diabetes and hypertension were sustained over long-term osilodrostat treatment in patients with Cushing's disease: A pooled analysis of LINC 3 and LINC 4

Endocrine Abstracts, 2024-05

2024

Volltextzugriff (PDF)

Management of recurrent and refractory Cushing's disease with reoperation and/or proton beam radiosurgery

Clinical neurosurgery, 2008, Vol.55, p.141

2008

Volltextzugriff (PDF)

Pooled analysis from two osilodrostat Phase III studies in Cushing's disease (LINC 3 and LINC 4): Clinical improvements according to urinary and late-night salivary cortisol levels

Endocrine Abstracts, 2023-05

2023

Volltextzugriff (PDF)

Pooled analysis of osilodrostat dosing across LINC 2, LINC 3 and LINC 4 in Cushing's disease

Endocrine Abstracts, 2023-05

2023

Volltextzugriff (PDF)

Growth hormone (GH) replacement therapy (GHRT) in patients with adult GH deficiency (AGHD) aged ≥60 years: data from NordiNet® IOS and the ANSWER Program

Endocrine Abstracts, 2022-05

2022

Volltextzugriff (PDF)

Change in androgens and adrenal hormones during long-term osilodrostat treatment in patients with Cushing's disease: Results from the Phase III, prospective LINC 3 study

Endocrine Abstracts, 2022-05

2022

Volltextzugriff (PDF)

Impact of urinary and late-night salivary cortisol levels on clinical signs of hypercortisolism and quality of life in patients with Cushing's disease treated with osilodrostat

Endocrine Abstracts, 2022-05

2022

Volltextzugriff (PDF)

In the Phase III studies LINC 3 and LINC 4, osilodrostat was effective and well tolerated in patients of Asian and non-Asian origin with Cushing's disease

Endocrine Abstracts, 2023-05

2023

Volltextzugriff (PDF)

The Role of the Clinical Laboratory in the Diagnosis of Cushing Syndrome

Pathology patterns reviews, 2003-12, Vol.120 (suppl_1), p.S38-S45

2003

Volltextzugriff (PDF)

Radiation Therapy in Patients With Cushing Disease

Encyclopedia of Endocrine Diseases, Second Edition, 2019, p.237-242

Second Edition, 2019

Volltextzugriff (PDF)

The role of bilateral inferior petrosal sinus sampling in the diagnosis of Cushing's syndrome

Arquivos brasileiros de endocrinologia e metabologia, 2007-11, Vol.51 (8), p.1329-1338

2007

Volltextzugriff (PDF)

Medical Therapies in Cushing’s Syndrome

The Hypothalamic-Pituitary-Adrenal Axis in Health and Disease, p.165-179

Volltextzugriff (PDF)

The potential role of the investigational somatostatin analog pasireotide (SOM230) in the treatment of neuroendocrine disorders

Current opinion in endocrinology & diabetes, 2006-08, Vol.13 (4), p.369-376

2006

Volltextzugriff (PDF)

1 – 16 von 16

Suche als RSS-Feed

Aktive Filter

Nur zeigenGeprüft (Peer-Review)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Mit Volltextzugriff
(3)

Publikationsform

Sprache

Englisch
(16)
Portugiesisch
(1)

Erscheinungsjahr

n.n

Kollektion

2 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

1 weiteren anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Diagnosis and Management of Pituitary Disorders

Improvements in diabetes and hypertension were sustained over long-term osilodrostat treatment in patients with Cushing's disease: A pooled analysis of LINC 3 and LINC 4

Management of recurrent and refractory Cushing's disease with reoperation and/or proton beam radiosurgery

Pooled analysis from two osilodrostat Phase III studies in Cushing's disease (LINC 3 and LINC 4): Clinical improvements according to urinary and late-night salivary cortisol levels

Pooled analysis of osilodrostat dosing across LINC 2, LINC 3 and LINC 4 in Cushing's disease

Growth hormone (GH) replacement therapy (GHRT) in patients with adult GH deficiency (AGHD) aged ≥60 years: data from NordiNet® IOS and the ANSWER Program

Change in androgens and adrenal hormones during long-term osilodrostat treatment in patients with Cushing's disease: Results from the Phase III, prospective LINC 3 study

Impact of urinary and late-night salivary cortisol levels on clinical signs of hypercortisolism and quality of life in patients with Cushing's disease treated with osilodrostat

Minimum data set for global monitoring of the safety and efficacy of growth hormone replacement in adults - an expert group recommendation

In the Phase III studies LINC 3 and LINC 4, osilodrostat was effective and well tolerated in patients of Asian and non-Asian origin with Cushing's disease

The Role of the Clinical Laboratory in the Diagnosis of Cushing Syndrome

Radiation Therapy in Patients With Cushing Disease

The role of bilateral inferior petrosal sinus sampling in the diagnosis of Cushing's syndrome

Medical Therapies in Cushing’s Syndrome

The potential role of the investigational somatostatin analog pasireotide (SOM230) in the treatment of neuroendocrine disorders

Paltusotine maintains IGF-1, GH, and symptom control in patients with acromegaly switched from injected octreotide or lanreotide monotherapy: Topline results from PATHFNDR-1, a phase 3, randomized, double-blind, placebo-controlled, multicenter study

Aktive Filter

Suchergebnisse filtern